Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program
Reading Time: < 1 minute ANNOUNCEMENT NO. 258 – 28 NOVEMBER 2024 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements
Structural measures and cost reductions in Lindab’s operations
Reading Time: 2 minutes Lindab is implementing structural measures and cost reductions, primarily within the ventilation business, in order to strengthen profitability and adjust the company’s fixed costs. Actions include a reduction of 180 full-time positions and structural measures involving the closure of 10 sites for
Metsä Group to publish a calculator for the carbon resources of its owner-members’ forests
Reading Time: 2 minutes Metsä Group’s Metsäverkko service will feature a new carbon calculator to help forest owners understand their forests’ carbon storage and carbon sinks. With good forest management, forest owners can nurture the carbon sink created by their forest. Metsä Group’s new
Paisabazaar Introduces Advanced Fraud Detection and Prevention System Using Cutting-Edge Technologies
Reading Time: 3 minutes Engine built on a combination of advanced data analytics, real-time monitoring, and machine learning techniques Internal risk scoring done for each consumer; medium risk ones monitored closely, high-risk consumers restricted from accessing offers The anti-fraud
Interim report for the period January 1 – September 30, 2024
Reading Time: 5 minutes Strengthened financial position and increased production paceIn the third quarter of 2024, Cinis Fertilizer delivered its first shipload of potassium sulfate to customer Van Iperen International, who in turn resold it to growers in approximately 25 countries worldwide. After the end of
Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024
Reading Time: 3 minutes Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will present breakthrough IND-enabling preclinical data on its drug candidate 177Lu-AKIR001 and the design of its first-in-human clinical trial at the Targeted Radiopharmaceuticals Summit Europe 2024 in Amsterdam, December 3-5. The data
PUMA Signs Blockbuster Long-Term Partnership With the Portuguese Football Federation
Reading Time: 3 minutes Herzogenaurach, Germany: Sports company PUMA has signed a long-term agreement with the Portuguese Football Federation (FPF), one of the world’s most popular national teams. Starting in 2025, PUMA will equip all male, female and youth teams as well as the federation’s
Keturah Announces Campaign for Its Developments, Introduces 5-Year Post-Handover Plan
Reading Time: 2 minutes Dubai, United Arab Emirates: Keturah, the revolutionary global luxury wellbeing real estate and hospitality concept has announced the launch of a sales campaign for The Ritz-Carlton Residences, Dubai, Creekside—part of the Keturah Resort—and Keturah Reserve which runs until 30 December.
Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (26.11.2024)
Reading Time: 2 minutes Kesko Corporation has on 27 November 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 26 November 2024, BlackRock, Inc.’s holding in Kesko Corporation exceeded the
Leqembi[®] launched in South Korea
Reading Time: 4 minutes Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult